Arlington, Va.—With only two treatment options for primary biliary cholangitis, some hepatologists have cast a new eye on an older class of drugs.
Fibrates, used for the treatment of dyslipidemia in the United States since the 1970s, had been shown to decrease levels of alkaline phosphatase (ALP), said Cynthia Levy, MD, FAASLD, an associate professor of medicine at the University of Miami Miller School of Medicine. By the late 1990s, she said, an interest in fibrates for the treatment of